Endocannabinoid Modulation of Amygdala Activity and Circuitry in Post-Traumatic Stress Disorder
Year: 2023
Type: dissertation
Study design: Observational Study
Abstract: Amygdalar dysfunction has been thought to underlie many psychiatric disorders. Most notably, the amygdala is hyperresponsive to threat in Post-Traumatic Stress Disorder (PTSD). PTSD is a distressing, prevalent disorder that is characterized by a cluster of symptoms that can be tied to amygdala dysfunction. Preclinical models suggest that decreased anandamide in the amygdala may drive a loss of top-down inhibition between frontal cortical areas and the amygdala, leading to amygdala hyperresponsivity to threat. Here we used neuroimaging to test the hypothesis that higher fatty acid amide hydrolase (FAAH), the main catabolic enzyme for anandamide, is associated with a decreased fronto-amygdalar functional connectivity and amygdala increased response to threat. 31 healthy control participants and 27 PTSD participants completed a positron emission tomography scan with the radiotracer for FAAH, [11C]CURB, a resting state functional magnetic resonance imaging session, as well as a functional magnetic resonance imaging session during a perceptual face processing task meant to activate the amygdala. [11C]CURB binding in the amygdala correlated negatively with fronto-amygdalar functional connectivity and positively with blood-oxygen-level-dependent (BOLD) signal during processing of angry and fearful faces in both healthy controls and PTSD. Our finding that higher levels of FAAH in the amygdala was associated with an increased amygdala response to a threatening social cues (angry and fearful faces) and decreased fronto-amygdalar functional connectivity is in line with preclinical and neuroimaging studies in humans and suggests the involvement of FAAH in modulating stress and anxiety in humans. The current study also lends support for the potential use of FAAH inhibitors for PTSD.
Source: TSpace (University of Toronto)
Author: Green, Duncan Grenville James
Institution: University of Toronto
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7132874981
